Form 4 for HNVR Hanover Bancorp, Inc. /MD
Accepted 2024-04-09 00:00:00 ET · period of report 2024-04-09 · accession 0001619964-24-000020 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-09 | 2024-04-09 | HNVR | Katz Michael David M.D. | Dir | M - OptEx | $10.00 | +7,057 | 154.3K | +5% | +$70.6K |
| D | 2024-04-09 | 2024-04-09 | HNVR | Katz Michael David M.D. | Dir | M - OptEx | $0.00 | -7,057 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-09 | M | A | 7,057 | $10.00 | 154,279 | D | — | — | |
| 2 | Derivative | Non-Qualified Stock Option | 2024-04-09 | M | D | 7,057 | $0.00 | 0 | D | $10.00 · 2017-10-01 to 2024-10-01 | 7,057 Common Stock |